These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24583311)

  • 1. Advances in the understanding of plaque composition and treatment options: year in review.
    Tomey MI; Narula J; Kovacic JC
    J Am Coll Cardiol; 2014 Apr; 63(16):1604-16. PubMed ID: 24583311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and the coronary plaque calcium "paradox": Insights from non-invasive and invasive imaging.
    Ferencik M; Chatzizisis YS
    Atherosclerosis; 2015 Aug; 241(2):783-5. PubMed ID: 26070488
    [No Abstract]   [Full Text] [Related]  

  • 3. Imaging of atherosclerosis: magnetic resonance imaging.
    Corti R; Fuster V
    Eur Heart J; 2011 Jul; 32(14):1709-19b. PubMed ID: 21508002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulnerable plaque and inflammation: potential clinical strategies.
    Drakopoulou M; Toutouzas K; Michelongona A; Tousoulis D; Stefanadis C
    Curr Pharm Des; 2011 Dec; 17(37):4190-209. PubMed ID: 22204378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of statins on high-risk atherosclerotic plaque associated with low endothelial shear stress.
    Takahashi S; Papafaklis MI; Sakamoto S; Antoniadis AP; Coskun AU; Feldman CL; Stone PH
    Curr Opin Lipidol; 2011 Oct; 22(5):358-64. PubMed ID: 21841484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An emerging paradigm in atherosclerosis: focus on subclinical disease.
    Miller M
    Postgrad Med; 2009 Mar; 121(2):49-59. PubMed ID: 19332962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stress.
    Andreou I; Antoniadis AP; Shishido K; Papafaklis MI; Koskinas KC; Chatzizisis YS; Coskun AU; Edelman ER; Feldman CL; Stone PH
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):261-75. PubMed ID: 25336461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
    Girotra S; Murarka S; Migrino RQ
    Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive imaging of arterial inflammation using FDG-PET/CT.
    Emami H; Tawakol A
    Curr Opin Lipidol; 2014 Dec; 25(6):431-7. PubMed ID: 25340479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vulnerable coronary plaque: update on imaging technologies.
    Rosa GM; Bauckneht M; Masoero G; Mach F; Quercioli A; Seitun S; Balbi M; Brunelli C; Parodi A; Nencioni A; Vuilleumier N; Montecucco F
    Thromb Haemost; 2013 Oct; 110(4):706-22. PubMed ID: 23803753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of coronary atherosclerosis: Current evidence and future perspectives.
    Koskinas KC; Windecker S; Räber L
    Trends Cardiovasc Med; 2016 Feb; 26(2):150-61. PubMed ID: 26089122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation.
    Abela GS
    J Clin Lipidol; 2010; 4(3):156-64. PubMed ID: 21122648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
    Simsek C; Garcia-Garcia HM; van Geuns RJ; Magro M; Girasis C; van Mieghem N; Lenzen M; de Boer S; Regar E; van der Giessen W; Raichlen J; Duckers HJ; Zijlstra F; van der Steen T; Boersma E; Serruys PW;
    EuroIntervention; 2012 Jun; 8(2):235-41. PubMed ID: 22717926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerotic plaque vulnerability in the statin era.
    Nilsson J
    Eur Heart J; 2017 Jun; 38(21):1638-1644. PubMed ID: 28387815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
    Bai W; Zheng X; Zhou L; Li H
    Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.
    Nidorf SM; Eikelboom JW; Thompson PL
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):45-52. PubMed ID: 24038016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis: Addition of niacin to optimal statin therapy does not affect plaque regression.
    Lim GB
    Nat Rev Cardiol; 2013 Oct; 10(10):554. PubMed ID: 23917468
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting the unstable plaque in acute coronary syndromes.
    Thompson PL; Nidorf SM; Eikelboom J
    Clin Ther; 2013 Aug; 35(8):1099-107. PubMed ID: 23973042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging the cellular biology of the carotid plaque.
    U-King-Im JM; Tang T; Moustafa RR; Baron JC; Warburton EA; Gillard JH
    Int J Stroke; 2007 May; 2(2):85-96. PubMed ID: 18705959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.